Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Hay

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 22, 2023
Emicizumab prophylaxis in haemophilia A with inhibitors: Three years follow-up from the UK Haemophilia Centre Doctors' Organisation (UKHCDO)Caroline Wall, Hua Xiang, Ben Palmer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 25, 2006
Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conferenceE Berntorp, A Shapiro, J Astermark, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 11, 2004
Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin-free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia AM D Tarantino, P W Collins, C R M Hay, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 9, 2019
Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studiesPeter Volkers, Kay-Martin Hanschmann, Thierry Calvez, et al.
Thrombosis and Haemostasis|April 17, 2015
Inhibitors in nonsevere haemophilia A: outcome and eradication strategiesAlice S van Velzen, Corien L Eckhardt, Daniel P Hart, et al.
Thrombosis and Haemostasis|May 6, 2020
A Novel, Enriched Population Pharmacokinetic Model for Recombinant Factor VIII-Fc Fusion Protein Concentrate in Hemophilia A PatientsLaura H Bukkems, Jessica M Heijdra, Mary Mathias, et al.
Blood|August 9, 2013
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia ACorien L Eckhardt, Alice S van Velzen, Marjolein Peters, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 22, 2023
Emicizumab prophylaxis in haemophilia A with inhibitors: Three years follow-up from the UK Haemophilia Centre Doctors' Organisation (UKHCDO)Caroline Wall, Hua Xiang, Ben Palmer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 25, 2006
Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conferenceE Berntorp, A Shapiro, J Astermark, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 11, 2004
Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin-free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia AM D Tarantino, P W Collins, C R M Hay, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 9, 2019
Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studiesPeter Volkers, Kay-Martin Hanschmann, Thierry Calvez, et al.
Thrombosis and Haemostasis|April 17, 2015
Inhibitors in nonsevere haemophilia A: outcome and eradication strategiesAlice S van Velzen, Corien L Eckhardt, Daniel P Hart, et al.
Thrombosis and Haemostasis|May 6, 2020
A Novel, Enriched Population Pharmacokinetic Model for Recombinant Factor VIII-Fc Fusion Protein Concentrate in Hemophilia A PatientsLaura H Bukkems, Jessica M Heijdra, Mary Mathias, et al.
Blood|August 9, 2013
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia ACorien L Eckhardt, Alice S van Velzen, Marjolein Peters, et al.
Pageof 6